Prokidney (PROK) Total Non-Current Liabilities (2021 - 2026)

Prokidney's (PROK) quarterly Total Non-Current Liabilities came in at $28.6 million in Q1 2026, down 19.01% year-on-year from $35.3 million in Q1 2025, and down 15.13% on a QoQ basis from $33.7 million in Q4 2025.

Prokidney (PROK) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends

Prokidney (PROK) has 6 years of Total Non-Current Liabilities data on file, last reported at $28.6 million in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 19.01% year-over-year to $28.6 million in Q1 2026; TTM through Mar 2026 was $28.6 million, a 19.01% decrease from a year earlier, with the FY2025 full-year figure at $33.7 million, down 12.87% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $28.6 million, down from $33.7 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for PROK reached as high as $38.7 million in Q4 2024 and fell as low as $11.6 million in Q3 2022.
  • Historically, Total Non-Current Liabilities has averaged $26.5 million across 5 years, with a median of $28.6 million in 2026.
  • Across the five-year window, Total Non-Current Liabilities soared 124.18% in 2023 and dropped 19.01% in 2026, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $12.8 million in 2022, then surged by 124.18% to $28.6 million in 2023, then jumped by 35.05% to $38.7 million in 2024, then retreated by 12.87% to $33.7 million in 2025, then slipped by 15.13% to $28.6 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $28.6 million in Q1 2026, $33.7 million in Q4 2025, and $32.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 4.45 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 110.28 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 19.49 Mn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.98 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 746.94 Mn
10 Prokidney 96.00 Mn 96.00 Mn - 28.61 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 28.61 Mn
Dec 31, 2025 33.71 Mn
Sep 30, 2025 32.31 Mn
Jun 30, 2025 31.78 Mn
Mar 31, 2025 35.32 Mn
Dec 31, 2024 38.69 Mn
Sep 30, 2024 30.55 Mn
Jun 30, 2024 26.23 Mn
Mar 31, 2024 24.16 Mn
Dec 31, 2023 28.65 Mn
Sep 30, 2023 23.10 Mn
Jun 30, 2023 26.78 Mn
Mar 31, 2023 13.75 Mn
Dec 31, 2022 12.78 Mn
Sep 30, 2022 11.56 Mn
Dec 31, 2021 13.38 Mn